The Latest Headlines at ETF Daily News
BlackRock, Inc. (NYSE:BLK) Sees Large Growth in Short Interest
BlackRock, Inc. (NYSE:BLK – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 1,780,000 shares, an increase of 12.7% from the... More of this article »
CVD Equipment Co. (NASDAQ:CVV) Sees Significant Growth in Short Interest
CVD Equipment Co. (NASDAQ:CVV – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 34,500 shares, an increase of 12.7%... More of this article »
Annexon (NASDAQ:ANNX) PT Raised to $13.00
Annexon (NASDAQ:ANNX – Get Free Report) had its price objective upped by research analysts at JPMorgan Chase & Co. from $11.00 to $13.00 in a report released on Monday, Benzinga reports. The brokerage currently has an “overweight”... More of this article »
Affimed (NASDAQ:AFMD) Rating Reiterated by Cantor Fitzgerald
Affimed (NASDAQ:AFMD – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a research report issued to clients and investors on Monday, Benzinga reports. Several... More of this article »
Affimed (NASDAQ:AFMD) Price Target Cut to $25.00 by Analysts at Wells Fargo & Company
Affimed (NASDAQ:AFMD – Get Free Report) had its price objective dropped by research analysts at Wells Fargo & Company from $30.00 to $25.00 in a research report issued to clients and investors on Monday, Benzinga reports.... More of this article »
Royal Bank of Canada Reaffirms “Outperform” Rating for Autodesk (NASDAQ:ADSK)
Autodesk (NASDAQ:ADSK – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a research note issued on Monday, Benzinga reports. They currently have... More of this article »
Acrivon Therapeutics (NASDAQ:ACRV) Stock Rating Reaffirmed by JMP Securities
Acrivon Therapeutics (NASDAQ:ACRV – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by research analysts at JMP Securities in a note issued to investors on Monday, Benzinga reports. They... More of this article »
Analysts Set New York Community Bancorp, Inc. (NYSE:NYCB) PT at $5.64
Shares of New York Community Bancorp, Inc. (NYSE:NYCB – Get Free Report) have been given an average rating of “Reduce” by the fifteen ratings firms that are covering the company, MarketBeat reports. Two investment... More of this article »
Oppenheimer Reiterates Outperform Rating for Achieve Life Sciences (NASDAQ:ACHV)
Achieve Life Sciences (NASDAQ:ACHV – Get Free Report)‘s stock had its “outperform” rating reaffirmed by research analysts at Oppenheimer in a research report issued on Monday, Benzinga reports. They currently... More of this article »
Brokerages Set Oncternal Therapeutics, Inc. (NASDAQ:ONCT) PT at $32.00
Shares of Oncternal Therapeutics, Inc. (NASDAQ:ONCT – Get Free Report) have earned a consensus rating of “Hold” from the six research firms that are presently covering the company, MarketBeat Ratings reports. Four... More of this article »
Essent Group Ltd. (NYSE:ESNT) Receives $56.25 Average Price Target from Analysts
Shares of Essent Group Ltd. (NYSE:ESNT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are covering the firm, MarketBeat.com reports. Three investment analysts... More of this article »
Brokerages Set Prosperity Bancshares, Inc. (NYSE:PB) PT at $68.79
Shares of Prosperity Bancshares, Inc. (NYSE:PB – Get Free Report) have earned an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the stock, MarketBeat Ratings reports.... More of this article »
EPR Properties (NYSE:EPR) Receives $48.05 Consensus Price Target from Analysts
Shares of EPR Properties (NYSE:EPR – Get Free Report) have been assigned a consensus recommendation of “Hold” from the ten research firms that are presently covering the stock, Marketbeat Ratings reports. One investment... More of this article »